Updated : Mon, September 19, 2022 @ 2:07 PM
Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that the company has launched catalogued assays for Stellaris™ RNA FISH. These assays fall into three groups – well characterized RNA targets (“foundation genes”) suitable for use as positive controls, oncogenes, and key mRNAs in the hypusine pathway.
To read the entire story, here's the full press release.
